𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chronic levodopa intake increases levodopa plasma bioavailability in patients with Parkinson's disease

✍ Scribed by Siegfried Muhlack; Dirk Woitalla; Jacob Welnic; Svenja Twiehaus; Horst Przuntek; Thomas Müller

Book ID
116766703
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
83 KB
Volume
363
Category
Article
ISSN
0304-3940

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Homocysteine levels after acute levodopa
Homocysteine levels after acute levodopa intake in patients with Parkinson's disease
✍ Thomas Müller; Wilfried Kuhn 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

## Abstract Levodopa (L‐dopa) administered with a dopadecarboxylase inhibitor (DDI) increases homocysteine plasma levels. This may support the onset of atherosclerosis‐related disorders and neuropsychiatric complications in patients with Parkinson's disease (PD). This homocysteine elevation is cons

Modest increase in plasma homocysteine f
Modest increase in plasma homocysteine follows levodopa initiation in Parkinson's disease
✍ Padraig E. O'Suilleabhain; Teodoro Bottiglieri; Richard B. Dewey Jr.; Shailja Sh 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 1 views

## Abstract Levodopa, typically ingested chronically at high daily doses, is predictably methylated by means of a series of reactions using B vitamins, which convert methionine to homocysteine. Elevated total plasma homocysteine (tHcy), a risk factor for dementia, has been found in PD patients usin

Cysteine elevation in levodopa-treated p
Cysteine elevation in levodopa-treated patients with Parkinson's disease
✍ Thomas Müller; Wilfried Kuhn 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 1 views

## Abstract Homocysteine, cysteine, and cysteinyl‐glycine are all metabolically interrelated. Levodopa/decarboxylase inhibitor (LD/DCI) administration increases total homocysteine (tHcy) plasma levels. Objectives were to investigate associations between LD/DCI intake, concentrations of tHcy, cystei

Hyperhomocysteinemia in levodopa-treated
Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia
✍ Stefano Zoccolella; Claudia dell'Aquila; Giovanni Abruzzese; Angelo Antonini; Ub 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

## Abstract Dementia is a frequent non‐motor feature of Parkinson's disease (PD). Elevated plasma homocysteine (Hcy) levels have been associated with both cognitive impairment and dementia. Increased Hcy levels have been observed in levodopa‐treated patients with PD. The objective of our study was